[REGN] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
07-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 37.96%
YoY- 372.80%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 4,951,700 2,422,900 2,169,500 1,927,800 1,582,447 1,226,827 1,098,077 28.50%
PBT 2,503,400 1,224,600 889,800 676,200 554,767 341,527 227,289 49.10%
Tax 274,400 75,400 97,800 -144,200 381,248 88,412 72,295 24.86%
NP 2,229,000 1,149,200 792,000 820,400 173,519 253,115 154,994 55.87%
Tax Rate -10.96% -6.16% -10.99% 21.33% -68.72% -25.89% -31.81% -
Total Cost 2,722,700 1,273,700 1,377,500 1,107,400 1,408,928 973,712 943,083 19.30%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 45.01 47.43 36.51 42.56 10.97 20.63 14.12 21.29%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS 20.99 10.90 7.25 7.58 1.62 2.41 1.49 55.34%
EPS Diluted 19.69 10.24 6.93 7.15 1.49 2.19 1.34 56.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.